Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform. The company's product pipeline in...
Leadership
Steven Lo
President, CEO & Director
Sean N. Tucker Ph.D.
Senior VP & Chief Scientific Officer
James F. Cummings M.D.
Chief Medical Officer
Jeroen Grasman M.B.A.
CFO, Principal Accounting Officer & Principal Financial Officer